Page 156 - Pharmacy Appeals 1/4/04 to 31/3/05

132 Financial statements

Provisions for liabilities and charges (prior year)

Provisions Ex-RHA ELS Restated DHSC ELGP ELSGP
CNST clinical

£0 0 0 s £0 0 0 s £0 0 0 s £0 0 0 s £0 0 0 s £0 0 0 s

Restated opening provision
57,011 1,111,961 35,957,145 2,681,471 387,475 0
for known claims
Opening provisions for IBNR 8 , 0 0 0 199,000 44,391,000 845,000 612,000 0

Restated1total provisions
65,011 1,310,961 80,348,145 3,526,471 999,475 0

as at 1April 2020
Movement in known claims
Transfer between schemes 0 0 0 0 (146,616) 146,616

Provided in the year 2,413 13,190 8,027,172 190,890 60,803 134,190
Provision not required
(3,752) (122,909) (4,131,228) (273,466) (69,731) (55,790)
written back
Unwinding of discount 1,023 18,848 439,075 42,305 1,278 778

Change in discount rate 297 4,572 16,186 12,853 3,440 287
Provisions utilised
(1,241) (23,034) (2,061,018) (61,629) (43,014) (18,619)
in the year

Movement in known claims (1,260) (109,333) 2,290,187 (89,047) (193,840) 207,462
Movement in IBNR

Transfer between schemes 0 0 0 0 (2 0 1 ,0 0 0 ) 2 0 1 , 0 0 0

Change in discount rate 0 1 , 0 0 0 165,000 1 , 0 0 0 6 , 0 0 0 3,000

Provided in the year (2 ,0 0 0 ) (55,000) (3,917,000) (228,000) (128,000) (13,000)

Movement in IBNR (2 ,0 0 0 ) (54,000) (3,752,000) (227,000) (323,000) 191,000
Closing provision for
55,751 1,002,628 38,247,332 2,592,424 193,635 207,462
known claims
Closing provisions for IBNR 6 , 0 0 0 145,000 40,639,000 618,000 289,000 191,000

Restated1total provision
61,751 1,147,628 78,886,332 3,210,424 482,635 398,462
as at 31 March 2021
Analysis of expected timing
of discounted cash flows2
Not later than one year 1 , 0 0 0 35,003 2,430,244 77,006 66,790 70,372

Later than one year and
7,005 143,086 11,767,324 315,188 173,922 157,870
not later than five years
Later than five years 53,746 969,539 64,688,764 2,818,230 241,923 170,220

Restated1total provision
61,751 1,147,628 78,886,332 3,210,424 482,635 398,462
as at 31 March 2021

The opening balance at 1 April 2020 and the closing balance at 31 March 2021 have been increased by £2,790 million and £2,457 million
retrospectively to reflect a prior period adjustment for 2020/21 in respect of the revaluation of the CNST known claims provision.
See Note 7.4 for further details of the revaluation.